TROY JOHNSON: Open Payments
NPI 1679523567 · REYNOLDSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 20 payments from 11 companies in 2025. Trend: 2023 $704 · 2024 $484 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Dexcom, Inc. | 2 | $54 |
| Novo Nordisk Inc | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: CAPLYTA, Dexcom G6 Transmitter, VRAYLAR, VOQUEZNA, Ozempic, REXULTI, LEQVIO, Veozah.
Industry payments across OH — which companies pay providers there.
